Injective (INJ) fell 10.17% today as heavy intraday selling pressure outweighed recent positive protocol and governance developments. The decline is reinforced by the asset testing the lower end ...
Injective (INJ) spiked 29.07% after securing key regulatory milestones, with institutional partnerships and an SEC-registered transfer agent status increasing investor demand. The surge is ...
Injective (INJ) is trading at $7.28, down 8.93% on the day after a volatile session that saw the asset open with a notable $0.32 gap. The price currently sits below its ...
Injective (INJ) fell 12.26% following elevated volatility, even as the platform recorded several notable institutional and regulatory developments. The decline is supported by short-term selling ...
Injective (INJ) is trading at $7.71, down 7.6% on the day, with the move taking it below its short- and medium-term moving averages but still holding above key long-term ...
Injective (INJ) surged 9.88% after becoming an SEC-registered transfer agent and expanding its real-world asset capabilities, drawing fresh institutional and regulatory momentum into the market. ...
Injective (INJ) is trading at $8.15 after climbing 7.07% on the day, with price action situated above its key moving averages and close to today's intraday high. ...
Injective (INJ) is holding near $8 after rising over 5% this past week as institutional activity drives momentum. Updates around ETF filings and new tokenization ...
Injective (INJ) is trading at $7.72, gaining 8.67% on the day. The price sits above its key moving averages, reflecting continued strength in the current ...
Injective (INJ) surged 10.15% after a sharp rise in derivatives activity highlighted speculative demand, with ongoing community token buybacks contributing to the attention on the protocol. The ...
Injective (INJ) is trading at $6.76 after falling 10.33% over the last 24 hours. The asset is currently below its short- and medium-term moving averages, but remains ...
Injective (INJ) slumped 11.53% as immediate selling pressure set in following its major whitepaper overhaul and protocol update. The weakness contradicts the underlying bullish trend structure, ...
Injective (INJ) fell 9.91% after a wave of selling pressure took hold, even as recent ecosystem incentives and the announcement of a potential Staked INJ ETF aimed to foster long-term growth. The ...
Injective (INJ) is trading at $7.34, down 6.47% on the day. The token currently sits below its short- and medium-term moving averages but remains above long-term trend ...
Injective (INJ) is trading at $8.17, posting a daily gain of 7.18%. The price currently sits near its session high and is positioned above its key moving averages on the ...
Regulatory momentum remains in focus for Injective (INJ) as it holds near $7.59, with buyers maintaining control through a quiet week. Hopes for greater institutional ...
Injective is positioning its token and institutional infrastructure for wider market access as U.S. applications tied to INJ continue moving through the regulatory process. Chief Executive Eric ...
Injective (INJ) is trading at $7.74, up 7.1% on the day. The asset is positioned above its key short- and medium-term moving averages, reflecting strong recent ...
Injective (INJ) is holding near $7.50 after slipping about 2% over the past week, as buyers keep control but momentum wanes. The recent dip reflects a pause following ...